3,4-Methylenedioxyamphetamine

Metabolite details

Identifier

NGBBVGZWCFBOGO-UHFFFAOYSA-N

InChI Key

NGBBVGZWCFBOGO-UHFFFAOYSA-N

IUPAC name

1-(1,3-benzodioxol-5-yl)propan-2-amine

Preferred name

3,4-Methylenedioxyamphetamine

INN name

—

Synonym

—

ChEBI

CHEBI:166520

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Sodium Butyrate mediates Histone Crotonylation and Alleviated Neonatal Rats Hypoxic-Ischemic Brain Injury Through Gut-Brain Axis (untargeted fecal metabolomics)
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• Metabolic profiling with UPLC-MS orbitrap of diatoms Coscinodiscus granii infected with parasitic oomycete Lagenisma coscinodisci

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Sham_vs_HIBD
• wild_type_vs_patA_deletion
• Healthy_vs_Infected